Lapatinib Tablets

Classification: Anticancer Medicine

Lapatinib Tablets

Lapatinib is a targeted therapy anticancer medicine that is used to treat different types of solid cancers and breast cancer.

Lapatinib is used in combination with letrozole or capecitabine.

It is widely used in breast cancers that have metastasized to the brain.

Lapatinib Tablets Uses

It is used to treat various types of breast cancers-

  • • HER-2 positive breast cancer
  • • Hormone receptor-positive breast cancer
  • • Hormone receptor-negative breast cancer
  • • Metastasized breast cancer
  • • Advanced-stage breast cancer

Lapakast -250 mg

Lapakast, available worldwide, is highly prescribed by doctors and oncologists. Lapakast 250mg is used to treat severe forms of breast cancer.

Lapakast is widely prescribed in combination with capecitabine for advanced breast cancer.

Aprazer Healthcare- Leaders in Oncology Care Treatments

Aprazer Healthcare is the top anticancer medicine manufacturer from India, exporting cancer care medicines and treatments worldwide.

Aprazer Healthcare is a name in quality drug manufacturing. We manufacture a range of cancer care medicines, including targeted therapy, hormonal therapy, and chemotherapy drugs.

Working of Lapatinib

Lapatinib consists of a smaller molecule that enters the cells.

It inhibits two proteins and offers a stronger blockade to cancer cell proliferation and multiplication.

Lapatinib Common Side Effects

Lapatinib inhibits the cell growth factors, inhibiting the growth protein, interfering the cell division, causing side effects.

  • • Diarrhea
  • • Skin rashes
  • • Nausea
  • • Vomiting
  • • Weakness
  • • Loss of appetite
  • • Hand–foot syndrome

Lapatinib Serious Side Effects

Lapatinib causes severe side effects, rare once

  • • Allergic reaction that can be severe.
  • • Cardiac cell damage
  • • Liver damage
  • • Lung toxicity
  • • Severe skin reaction

Precautions for Lapatinib

Lapatinib tablets should be used carefully in patients with a medical history-

  • • Arrhythmia
  • • Cardiac diseases
  • • Lung diseases
  • • Allergic reactions

Warning for Lapatinib

Lapatinib should be avoided in women who are pregnant.

It should be avoided in women feeding the child.

People should effectively maintain contraception.

Drug Interactions

The Lapatinib tablets show a severe drug reaction with –

  • • Drugs that cause QT prolongation.
  • • Antibiotics
  • • Antifungal agents
  • • Corticosteroids
  • • Digoxin

Monitoring Consideration

Regular monitoring of various side-effects –

  • • Heart functions
  • • Electrolytes
  • • Liver functions
  • • Urine changes
  • • Serum electrolytes

Conclusion

Lapatinib (Lapkast) is the globally recognized anticancer medicine for breast cancer. It is a targeted therapy drug that inhibits cancer formation. Lapatinib therapy should be carefully monitored for elevated Liver enzymes, ECGs and other skin conditions.